The Biomarkers API provides a wealth of reliable, high-quality, continually updated information supporting biomarker research at every stage of the drug R&D process. The underlying database is the first one to standardize terminology and classify biomarkers reliably into lifecycle phases and disciplines. It helps improve cost efficiency, predict and minimize risk and avoid late stage attrition. The Biomarker Use data are supported by Biomarker, Patent and Reference records.
Biomarkers API can help you to
Entities diagram (Colour coding – green: main entity | purple: supporting entities)
Search biomarker use results and retrieve biomarkers use, biomarker, patent and reference records.
Search and browse clinical trials, literature, biomarkers and drug records as well as link through to original articles via Web of Science and to compare many trials side-by-side. Some records have associated epidemiology data.
APIs involved in this demo: Clinical, Ontologies and Investigational Drugs APIs to access drug details and Biomarkers API to access biomarker use and biomarker details.
This Pipeline Pilot protocol finds commercially significant trials for the chosen indication (Melanoma by default) where biomarkers are captured for the trial. The first 5 trials will be listed in summary form.
Clicking the hyperlinked trial ID will display a biomarker trial report. This report displays a biomarker summary for each biomarker in the trial in addtion to the first 5 biomarker use records for each biomarker.
APIs involved in this demo: Clinical and Biomarkers APIs.
This demo answers the questions:
APIs involved in this demo: Clinical and Investigational Drugs APIs.
The following terms govern your use of Cortellis Labs apps: